Changes in glomerular filtration rate and renal plasma flow in cirrhotic rats during converting enzyme inhibition

Renal Failure

Volumn 20, Issue 1, 1998, Pages 65-74

  Ibarra, Fernando R ^a   Galcerán, Tilde ^a   Oddo, Elisabet ^a   Arrizurieta, Elvira ^a  

^a INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

Author keywords

Angiotensin converting enzyme inhibition; Cirrhosis

Indexed keywords

INDOCYANINE GREEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ENZYME INHIBITION; GLOMERULUS FILTRATION RATE; HYPOTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER FUNCTION; NATRIURESIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SODIUM RETENTION; VASODILATATION; WATER RETENTION;

EID: 0031887167     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229809045090     Document Type: Article

References (33)

1. Better OS, Schrier RW: Disturbed volume homeostasis in patients with cirrhosis of the liver. Kidney Int 23:303-311, 1983.
2. Skorecki KL, Brenner BM: Body fluid homeostasis in congestive heart failure and cirrhosis with ascites. Am J Med 72:328-338, 1982.
3. Hollenberg NK: Renin, angiotensin and kidney: Assessment by pharmacological interruption of the renin-angiotensin system In: Epstein M (ed); The kidney in Liver Disease. Baltimore, Williams & Wilkins, 1988, pp 374-389.
4. Gavras H, Chang Seng L, Brunner HR: Redistribution of regional blood flow after inhibition of the angiotensin converting enzyme. Cir Res (supp 1) 48:89-93, 1978.
5. Mimran A, Jover B, Casellas D: Renal adaptation to sodium deprivation. Effect of Captopril in the rat. Am J Med (suppl) 31:14-21, 1984.
6. Arroyo V, Bosch J, Mauri M, Ribera F, Navarro-López F, Rodes J: Effect of angiotensin-II blockade on systemic hemodynamic and on the reninangiotensin-aldosterone system in cirrhosis with ascites. Eur J Clin Invest 11:221-229, 1981.
7. Pariente AE, Bataille C, Bercoff E, Lebrec D: Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites. Gastroenterology 88:1255-1259, 1985.
8. Bosch J, Arroyo V, Betriu A, Mas A, Carrilho F, Rivera F, Navarro-López F, Rodes J: Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology 78:92-99, 1980.
9. Ibarra FR, Afione C, Garzón D, Barontini M, Santos JC, Arrizurieta E: Portal pressure, renal function and hormonal profile after acute and chronic captopril treatment in cirrhosis. Eur J Clin Pharmacol 43:477-482, 1992.
10. Lopez Novoa JM: Pathophysiological features of the carbontetrachloride/phenobarbital model of experimental liver cirrhosis in rats In: Epstein M (ed); The Kidney in Liver Disease. Baltimore, Williams & Wilkins, 1988, pp 309-327.
11. Bradley SE: The hepatic circulation. In: Hamilton WE (ed); Handbook of Physiology, Circulation II. Washington DC, American Physiological Society, 1963, pp 1387-1438.
12. Caesar J, Sheldon S, Chiandussi L, Guevara L, Sherlock S: The use of Indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 21:43-57,1961.
13. Young MK, Raisz LG: The anthrone method. Proc Soc Exper Biol and Med 80:771-774,1952.
14. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M: The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 24:388404, 1945.
15. Snedecor GW, Cochran WG: Statistical Methods, ed. Iowa, Iowa State University Press, Ames, 1967, p 258
16. Linas SL, Anderson RJ, Guggenheim SJ, Robertson GL, Berl T. Role of vasopressin in impaired water excretion in conscious rats with experimental cirrhosis Kidney Int 20: 173-180, 1981
17. Daskalopoulos G, Pinzani M, Murray N, Hirschberg R, Zipser RD: Effects of captopril on renal function in patients with cirrhosis and ascites. J Hepatol 4:330-336,1987.
18. Koepke JP, Jones S, DiBona GF. Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats. Am J Physiol, 252:R1019-1023, 1987.
19. Levy M, Wexler MJ, Fechner C: Renal perfusion in dogs with experimental cirrhosis: role of prostaglandins. Am J Physiol, 245:F521-527, 1983.
20. Levy M, Wexler M: Sodium excretion in dogs with low-grade caval constriction: role of hepatic nerves. Am J Physiol, 253:F672-678, 1987.
21. Wilkinson MD, Smith IK, Williams R: Changes in plasma renin activity in cirrhosis: A reappraisal based on studies in 67 patients and "Low-renin" cirrhosis. Hypertension 1:125-129,1979.
22. Fernández-Munoz C, Caramelo C, Santos JC, Blanchart A, Hernando L, López-Novoa JM: Systemic and splanchnic hemodynamic disturbances in concious rats with experimental liver cirrhosis without ascites. Am J Physiol, 249:G316-G320, 1985.
23. Jiménez W, Martínez-Pardo A, Arroyo V, Bruix J, Rimola A, Gaya J, Rivera F, Rodés J: Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis. Hepatology 5:245-250, 1955.
24. 1 receptor mRNA in rat kidney. Kidney Int 46: 973-979, 1994.
25. Keiding S: Hepatic clearance and liver blood flow. J Hepatol 4:393-398, 1987.
26. Reichen J, Egger B, Ohara N, Zeltner TB, Zysset T, Zimmermann A: Determinants of hepatic function in liver cirrhosis in the rat. J Clin Invest 82:2068-2073,1988.
27. 1 receptor. Am J Physiol 264:F989-995, 1993.
28. Grollman E: Calcium signals in the liver. In Arias IM, Jalsoby WB, Popper H, Schachter D, Shafity DA (eds): The Liver; Biology and Pathobiology. New York, Raven Press Ltd, 1988, pp 777-783.
29. Tsai HH, Lees KR, Danesh BJ, Reid JL: The acute and chronic effects of perindopril on renal sodium and water handling in patients with compensated hepatic cirrhosis. Eur J of Gastroenterol & Hepatol 4:289-294,1992.
30. Suki W, Rouse D: Renal tubular actions of antihypertensive agents. Kidney Int 25:160-161, 1988.
31. Usberti M, Di Minno G, Ungaro B, Cianciaruso A, Martucci F, Pannain M, Cerbone AM, Andreucci V: Angiotensin II inhibition with captopril on plasma ADH, PG synthesis and renal function in humans Am J Physiol, 250:F986-990, 1986.
32. Zusman RM: Renin and non renin mediated antihypertensive actions of converting enzyme inhibitors. Kidney Int 25:963-983, 1984.
33. Palatini P, Dabbeni-Sala F, Finotti P: Inhibition of dopamine-beta hydroxylase by captopril. Biochem Pharmacol 38:1011-1013, 1989.